Who owns CANDEL THERAPEUTICS, INC?
- Ticker: CADL
- CUSIP Number: 137404109
Tip: Access positions for across all investors
Analyze quarterly positions in Candel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Candel Therapeutics stock
Who bought or sold CANDEL THERAPEUTICS, INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Northpond Ventures | 1.9M | $3.1M | 0% | Mar 2024 |
|
| Sands Capital Ventures | 812k | $1.3M | 0% | Mar 2024 |
|
| Vanguard Group | 541k | $855k | 27% | Mar 2024 |
|
| Geode Capital Management | 146k | $230k | 5% | Mar 2024 |
|
| Bridgeway Capital Management | 83k | $131k | -38% | Mar 2024 |
|
| Baystate Wealth Management | 77k | $113k | -21% | Dec 2023 |
|
| BlackRock | 48k | $75k | -5% | Mar 2024 |
|
| Mariner Wealth Advisors | 34k | $53k | 100% | Mar 2024 |
|
| Resources Investment Advisors | 30k | $47k | 17% | Mar 2024 |
|
| Northern Trust | 20k | $31k | -1% | Mar 2024 |
|
| Commonwealth Equity Services | 14k | $22k | 100% | Mar 2024 |
|
| Two Sigma Investments | 13k | $21k | 100% | Mar 2024 |
|
| Tower Research Capital | 3.7k | $5.8k | -57% | Mar 2024 |
|
| Jpmorgan Chase & Co | 221.00 | $349.312600 | 6% | Mar 2024 |
|
| Wells Fargo & Company | 115.00 | $181.999000 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 69.00 | $0 | 130% | Mar 2024 |
|
| UBS Group | 10.00 | $16.000000 | -100% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Candel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FMR | Sep 2023 | 439k | $408k |
| Citadel Advisors | Dec 2023 | 17k | $25k |
| Two Sigma Securities | Dec 2023 | 17k | $24k |
| Vontobel Holding | Dec 2023 | 10k | $15k |
| Bank of America Corporation | Dec 2023 | 18.00 | $25.999200 |